Background
Introduction
Since their introduction two decades ago, proton pump inhibitors (PPIs) became the mainstay in gastro esophageal reflux (GERD), peptic ulcer disease (PUD), persistent non-steroidal antiinflammatory drug (NSAID) treatment and generalized dyspepsia (heartburn) [1] [2] [3] . PPIs form a class of drugs that is widely prescribed, with millions of chronic users worldwide. [4] . The most recognized side effect of all marketed PPIs is proton-pump inhibitor-induced hypomagnesemia (PPIH) [5, 6] . First described in 2006, thereafter many single case-reports and small case-series on the subject emerged [7] [8] [9] . The U.S. Food-and Drug Administration (FDA) issued a warning in 2011 and the critical assessment of their adverse events databank showed that more cases existed than was previously assumed [10] . It is widely anticipated that PPIH is the consequence of intestinal Mg 2+ malabsorption, since a renal leak was never detected [6, 11] . An underappreciated aspect of PPIH is frequent secondary electrolyte disturbances such as hypocalcemia and hypokalemia [8, 12, 13] . However, the clinical significance of reduced calcium (Ca 2+ ) levels was emphasized by several dozens of studies showing increased risk of bone fractures after chronic PPI use [14] .
The exact mechanism by which PPIs cause mineral deficits is currently under debate. Recent in vitro data suggest that omeprazole inhibits passive paracellular Mg 2+ fluxes, predominantly present in the small intestine [15, 16] . Moreover, in vivo studies indicate that omeprazole directly interferes with important transcellular Mg 2+ transport mechanisms of the colon [17] . In the tight epithelium of colon, the epithelial Mg 2+ channel, transient receptor potential melastatin member 6 (TRPM6), facilitates the absorption of Mg 2+ [18] [19] [20] . Omeprazole specifically enhances the mRNA levels of Trpm6 as well as Atp12a, which encodes the non-gastric proton potassium adenosine triphosphatase (colonic H + ,K + -ATPase or cHK-α) [17] . It has been suggested that omeprazole locally inhibits the cHK-α, leading to an increased luminal pH in the colon [17] . Given that TRPM6-mediated Mg 2+ transport is dependent on the protonation of the channel itself, PPIinduced pH increases will reduce TRPM6-mediated Mg 2+ influx [21] [22] [23] .
To date, defined intervention strategies preventing PPIH have not been established in clinical practice. Local luminal acidification of the colon may rescue intestinal Mg 2+ absorption and, therefore, provides a promising approach to prevent PPIH. Interestingly, the dietary application of the fructan fiber inulin has been proposed to reduce intestinal pH [24] . Ingested inulin fibers are fermented in the large intestine by bifidogenic gut bacteria, resulting in shortchain fatty acids (SCFA), which in turn acidify the colon [25] . The stimulating action of SCFA on intestinal Mg 2+ absorption by reducing the luminal pH has already been described decades ago, but has been largely overlooked since then [26, 27] . However, inulin fibers have been shown to stimulate Mg 2+ and Ca 2+ absorption in the colon of mice and humans [28, 29] . Moreover, inulin fibers are capable of modulating intestinal and renal Trpm6 mRNA expression [30] .
Here, an intervention study was performed using dietary oligfructose-enriched inulin fibers in control-and omeprazole-treated wildtype C57BL/6J male mice. The aim was to enhance intestinal Mg 2+ and Ca 2+ absorption in order to counteract omeprazole-induced defects in mineral uptake. Additionally, the mRNA expression pattern of the Mg 2+ and Ca 2+ transporting proteins expressed in the cecum, colon and kidney was determined by qRT-PCR.
Materials and Methods

Animal studies
This study was carried out in strict compliance with the legal Dutch animal welfare act. All experimental procedures were approved by the animal ethics board of the Radboud University Nijmegen (permit-no: RU-DEC 2014-032) and all efforts were made to minimize suffering of the animals. Wild-type C57BL/6J mice (n = 40 males, 9 weeks old) were purchased from Charles River, the Netherlands. The animals were randomly allocated into four experimental groups of n = 10 mice. Before the experiment was started, the animals underwent acclimatization for one week under temperature-and light-controlled conditions with ad-libitum access to standard pellet chow (SSNIFF Spezialdiäten GmbH, Germany) and drinking water. The control diet consisted of standard pellet chow, the experimental inulin diet additionally contained 10% (w/w) inulin fiber product (Orafti Synergy1, Beneo-Orafti, Belgium). Omeprazole (Fagron, the Netherlands) was dispersed in a solution (vehicle) containing 0.5% (w/v) methylcellulose and 0.2% (w/v) NaHCO 3 (adjusted with NaOH to pH 9.0). During the 14 days of the experimental phase, the mice received a daily dose of 20 mg omeprazole per kilogram bodyweight, administered via oral gavage once a day, or vehicle. The health of the animals was regularly checked. For urine and feces collection, animals were housed individually in metabolic cages for 24 h. At the experimental endpoint, animals were anesthetized with isoflurane (5% v/ v), blood sampling was performed by orbital sinus bleeding and subsequently the mice were sacrificed by cervical dislocation. Kidneys, cecum and colon segments were extracted and cleaned, fecal contents of cecum and colon were preserved and all samples were snap frozen in liquid nitrogen. 2+ and Ca 2+ were cross-verified using a serum standard solution (Precinorm U, Roche, Switzerland). The SCFA profile of cecal and colonic contents was determined on a Chrompack Model CP 9001 gas chromatograph (Agilent, USA) equipped with a 2 m x 2 mm column, packed with 10% SP 1200/1% H2PO4 on 80/100 Chromosorb W AW (Sigma, UK). Samples were centrifuged at 15,000 x g for 10 min. Subsequently fecal water (supernatant) was extracted and 1:1 (v/v) diluted with a solution (internal standard) of 30 mmol/L of 2-ethylbutyric acid in 100% formic acid, resulting in a 9% (v/v) formic acid suspension used for injection into the gas chromatograph.
Analytical procedures
Quantitative real-time PCR
Total RNA was extracted from tissues using TRIzol reagent (Invitrogen, UK) according to the manufacturer's protocol. Obtained RNA was subjected to DNase treatment (Promega, USA). Subsequently, the purified RNA was reverse transcribed with murine leukemia virus reverse transcriptase (Invitrogen, the Netherlands).
The mRNA expression was quantified by SYBR Green (BioRad, USA) real-time PCR on a CFX96 real-time detection system (BioRad, USA). Real-time PCR primers (Biolegio, the Netherlands) were designed with Primer 3 software (Whitehead Institute for Biomedical Research, USA). Primer sequences are provided in S1 Table. Obtained mRNA levels were normalized by glyceraldehyde 3-phosphate dehydrogenase (Gapdh) as an endogenous control. Relative mRNA expression was analyzed according to the Livak method (2 -ΔΔcT ) and annotated as times-fold change of expression compared to control [31] .
Statistics
Values are expressed as means ± SEM. The differences between single groups of control, inulin-only, omeprazole-only and omeprazole + inulin treated mice were tested by using one-way ANOVA with a Tuckey correction. Differences between groups were regarded to be statistically significant when P < 0.05. The analysis of the datasets was performed using GraphPad Prism (PC version 6).
Results
Omeprazole treatment results in reduced serum Mg
2+
In this study, we aimed to evaluate the application of dietary oligofructose-enriched inulin fibers as a means to prevent PPIH. Therefore, wildtype C57BL6/J mice were supplemented with vehicle or omeprazole for 14 days. In addition, the vehicle group and the omeprazole group were subdivided into two groups fed with a normal diet or with a diet containing 10% w/ w oligofructose-enriched inulin fructan fibers, making a total of four experimental groups (Table 1) . After 14 days of experimental procedure, the mean bodyweight of the animals was equal (Table 1) . Compared to the control group, food intake, water intake and diuresis did not change due to omeprazole or inulin treatment. The mean fecal output of the inulin-omeprazole-treated group was significantly elevated compared to mice receiving only omeprazole (1.5 ± 0.2 g and 1.05 ± 0.06 g, respectively, P < 0.05).
To study the effect of omeprazole and a possible combinatory effect of the inulin diet on Mg 2+ homeostasis, serum Mg 2+ concentration, 24 h urinary Mg 2+ and fecal Mg 2+ excretion were determined. Omeprazole-treated and inulin-omeprazole-treated mice had significantly lower serum Mg 2+ levels compared to control mice ((1.26 ± 0.03 mmol/L, 1.23 ± 0.04 mmol/L) and 1.39 ± 0.02 mmol/L, respectively, P < 0.05 Fig 1A) . Urinary Mg 2+ excretion was significantly increased in the inulin-omeprazole group compared to omeprazole-treated group (1.0 ± 0.1 mmol/L and 1.23 ± 0.08 mmol/L, respectively, Ρ < 0.05 Fig 1B) . Fecal Mg 2+ excretion was equal among all groups (Fig 1C) . The results are expressed as means ± SEM (n = 10). Significant differences between the two omeprazole-treated groups are indicated by # with P < 0.05. Mice have been fed a control diet or a diet containing 10% (w/w) oligofructose enriched inulin fibers. Dietary inulin reduces the expression of Trpm6
To identify the effect of omeprazole treatment and inulin-enriched diets, the mRNA levels of genes involved in Mg 2+ transport were evaluated. In cecum, addition of inulin to the diet significantly reduced Trpm6 mRNA levels by 32 ± 7% compared to vehicle-treated mice on the normal diet and by 40 ± 3% in mice that received inulin combined with omeprazole (Fig 2A) . In colon, the Trpm6 mRNA levels were not significantly different between the groups (Fig 2B) . Accordingly, Trpm6 mRNA levels were reduced by 29 ± 5% in the inulin group compared to the control group, and the mice of the inulin-omeprazole group had 29 ± 4% lower Trpm6 mRNA levels compared to the omeprazole only treated mice (Fig 2C) . The expression of the nongastric H + ,K + -ATPase encoded by Atp12a was reduced from 149 ± 12% in the omeprazole-only group down to 58 ± 14% in the inulin-omeprazole group (Fig 2D) . In colon and in kidney there were no significant differences present (Fig 2D  and 2E ).
Dietary inulin rescues omeprazole-induced low serum Ca
Serum Ca 2+ of the omeprazole-treated mice was slightly, but, significantly reduced compared to the vehicle-treated control group (2.19 ± 0.01 mmol/L and 2.27 ± 0.01 mmol/L, respectively, P < 0.05, Fig 3A) . Importantly, application of the inulin diet during omeprazole treatment resulted in a correction of serum Ca 2+ to the level of control mice and inulin-only treated mice. This is reflected in the 24 h urinary Ca 2+ excretion; omeprazole treated mice displayed a reduced urinary Ca 2+ excretion compared to the mice on the inulin diet 2.7 ± 0.3 μmol/24 h and 4.3 ± 0.5 μmol/24 h, respectively, P < 0.05 Fig 3B) . The fecal excretion of Ca 2+ in all groups was significantly lower compared to control mice (for inulin 0.55 ± 0.03 mmol/24 h, for omeprazole 0.48 ± 0.03 mmol/24 h, for inulin-omeprazole 0.55 ± 0.03 mmol/24 h vs. control 0.93 ± 0.07 mmol/24 h, Fig 3C) . . All values are presented as means ± SEM (n = 10 per group). Significant differences between control vs. both omeprazole groups are indicated by * with P < 0.05, significant differences between the omeprazole-treated groups are annotated by # with P < 0.05. The serum K + level of the inulin-omeprazole group was significantly lower than that of the control group (4.8 ± 0.1 mmol/L and 5.08 ± 0.05 mmol/L, respectively, P < 0.05, Fig 3D) . There were no significant differences in serum Na + levels observed (Fig 3E) .
Inulin prevents PPI-induced upregulation of calciotropic genes
In order to investigate if the treatment regimens induced differential gene regulation, the mRNA levels of the main calciotropic genes in the intestine, Trpv6 together with S100g and, Trpv5 and Calb1 expressed in the kidney were quantified. In cecum no significant differences were observed for Trpv6 mRNA levels within the respective diet groups, however in colon Trpv6 expression was significantly increased to 170 ± 14% compared to the control group ( Fig  4A and 4B) . Addition of inulin completely abolished this increase. In the kidney Trpv5 mRNA levels of both omeprazole-treated groups were not significantly different from the respective control groups on normal diets. In the intestine, the expression pattern of S100g was similar in cecum and colon. In both segments, the mRNA levels in omeprazole-only treated mice were significantly increased compared to all the other groups (Fig 4D and 4E) . In cecum, S100g mRNA levels were increased to 284 ± 32% compared to the control group and in colon to 291 ± 24%. In contrast, no significant differences were observed for the mRNA levels of Calb1 in the kidney (Fig 4F) .
Dietary inulin enhances short-chain fatty acid production
To verify whether inulin stimulated intestinal bifidogenic fermentation, SCFA profiles of cecal and colonic contents were determined. In cecum, inulin significantly increased n-butyric acid concentration from 20 ± 2 mmol/L in the control group to 41 ± 3 mmol/L in the inulin group and to 28.7 ± 0.6 mmol/L in the inulin-omeprazole group (P < 0.05, Fig 5A) . Likewise, in colon inulin significantly increased n-butyric acid concentration from 23.1 ± 0.9 mmol/L in the control group to 43 ± 3 mmol/L in the inulin group and to 33 ± 2 mmol/L in the inulin-omeprazole group (P < 0.05, Fig 5C) . No differences between the groups were observed for propionic acid in both intestinal segments (Fig 5B and 5D) . Moreover, in cecum and colon no differences were observed in the other minor SCFA fractions (with concentrations < 1.5 mmol/L) consisting of iso-propionic acid and iso-butyric acid (data not shown).
Discussion
This is the first study evaluating a treatment strategy for PPI-induced mineral disturbances in mice. PPI-induced hypocalcemia was counteracted by dietary inulin application. However, a correction of serum Mg 2+ was not achieved by this approach.
There is a large body of literature showing that dietary inulin fibers stimulate Mg 2+ and Ca 2+ absorption in rodents and humans [28, 32] . The most potent stimulation of mineral absorption is achieved by a mixture of long-and short-chain oligofructose-enriched inulin, since certain strains of gut bacteria have a preference for inulin fibers based on chain length [33, 34] . In accordance with several other studies, the inulin product was given at a 10% (w/w) dose added to regular chow [30, 35] . In rats and mice, it has been demonstrated before that at this dose inulin induces luminal acidification in less than one week, enhancing the solubilization of minerals and which subsequently results in osmotic attraction of water in the colon [34, 36] . In the present study a similar effect was demonstrated, since humidification of the feces of the inulin-treated mice was observed, indicating that inulin activated bacterial fermentation also under omeprazole treatment. Indeed, irrespective of the omeprazole treatment n-butyric acid, the main end-metabolite of bifidogenic inulin fermentation, was increased in cecum and colon of the mice on an inulin diet (Fig 5A and Fig 5C) [37, 38] . This result supports previous findings that SCFA, and in particular n-butryic acid, increase Ca 2+ and Mg 2+ absorption [27, 39] . The mice on the normal diet showed a significant reduction of serum Ca 2+ values after 14 days of omeprazole-treatment (Fig 3A) . Importantly, concomitant application of dietary inulin prevented this reduction of serum Ca 2+ values. A pronounced decrease of intestinal Ca 2+ absorption by PPIs has already been evidenced in early studies and has been confirmed in recent reports [13, 40] . To the authors knowledge, this is the first time that a treatment is successful to prevent PPI-induced Ca 2+ disturbances.
Although direct measurements of intestinal Ca 2+ absorption were not performed in this study, the expression profile suggests that intestinal Ca 2+ transport is affected. In cecum and in colon, omeprazole induced strong increases of intestinal Trpv6, together with its Ca 2+ -binding protein encoded by S100g in order to correct reduced serum Ca 2+ levels (Fig 4D and 4E ). The addition of inulin completely abolished this increment, which is also reflected in normalized serum Ca 2+ (Fig 4A) . [19] . Interestingly, Trpm6 mRNA expression in cecum was significantly decreased in mice receiving inulin-enriched diets independently of omeprazole treatment (Fig 2A) . Given that [30] . Because the nephron is devoid from any microbiota, inulin will not directly affect the intratubular pH in the nephron. This is confirmed by the absence of effects of inulin on Atp12a expression in the kidney. Food intake was increased in inulin-omeprazole-treated mice compared to omeprazoletreated mice. However, it is unlikely that this explains the increased serum Ca 2+ values since serum values of Na + , Mg 2+ and K + were not altered in inulin-omeprazole-treated mice. In our study, serum K + values were reduced in both omeprazole-treated groups, following the same pattern as serum Mg 2+ values. In the clinic, hypokalemia is often secondary to hypomagnesemia and frequently observed in PPIH patients [5, 8, 12, 13] . The general accepted hypothesis to explain this phenomenon is that hypomagnesemia results in increased K + secretion in the nephron. Given that intracellular Mg 2+ inhibits the renal ROMK K + channel to reduce renal K + secretion, hypomagnesemia may relieve this inhibition and thus increases K + secretion [43] .
The outcomes of our study highlight the need for reissuing the impact of PPIs on Ca Supporting Information S1 ARRIVE Checklist. (PDF) S1 
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